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Microphthalmia-associated transcription factor (MITF) is a master regulator of pigmented cell survival and dif-
ferentiation with direct transcriptional links to cell cycle, apoptosis and pigmentation. In mouse, Mitf is
expressed early and uniformly in optic vesicle (OV) cells as they evaginate from the developing neural tube,
and nullMitfmutations result in microphthalmia and pigmentation defects. However, homozygous mutations
in MITF have not been identified in humans; therefore, little is known about its role in human retinogenesis.
We used a human embryonic stem cell (hESC) model that recapitulates numerous aspects of retinal develop-
ment, includingOVspecification and formation of retinal pigment epithelium (RPE) andneural retina progenitor
cells (NRPCs), to investigate the earliest roles of MITF. During hESC differentiation toward a retinal lineage, a
subset of MITF isoforms was expressed in a sequence and tissue distribution similar to that observed in
mice. In addition, we found that promoters for theMITF-A, -D and -H isoforms were directly targeted by Visual
Systems Homeobox 2 (VSX2), a transcription factor involved in patterning the OV toward a NRPC fate. We
then manipulated MITF RNA and protein levels at early developmental stages and observed decreased expres-
sion of eye field transcription factors, reduced early OV cell proliferation and disrupted RPE maturation. This
work provides a foundation for investigating MITF and other highly complex, multi-purposed transcription
factors in a dynamic human developmental model system.
INTRODUCTION
Vertebrate eye morphogenesis is comprised of a series of tem-
porally and spatially defined events controlled by extrinsic
cues, intrinsic factors and signaling networks. Early on, a
cohort of transcription factors including Pax6 and Otx2
contribute to the specification of the eye field (EF) from the
anterior neuroepithelium (AN) of the developing neural plate.
Shortly thereafter, evagination of the optic vesicles (OVs)
from the anterior neural tube provides the first clear morpho-
logical indication of the future retina. At this stage, the OV is
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unpatterned and can adopt either a retinal pigment epithelium
(RPE), neural retina or optic stalk fate (1–3).
In the mouse, primitive OV cells uniformly express
microphthalmia-associated transcription factor (Mitf), a basic
helix–loop–helix leucine zipper protein predominantly known
for its role in the survival and differentiation of pigmented cells
(4–10). Multipotent Mitf+ OV cells, which are unpigmented,
respond to multiple intrinsic and extrinsic factors that guide
their developmental trajectory, but the function of Mitf in these
cells is largely unknown. Evidence from mouse and chick has
shown that upregulation of Visual systems homeobox 2 (Vsx2)
in the distal OV coincides with a decrease in Mitf expression
and establishment of the neural retina domain (4,11–14). In con-
trast, the dorsal region of the OV retains Mitf expression and
develops into RPE in response to local signaling cues (15–18).
The ventral region of the OV also responds to morphogen gradi-
ents, resulting in loss of Mitf expression and formation of the
optic stalk (19,20).
While the role of Mitf in the unpigmented primitive OV
remains unclear, in pigmented cells it is known to target genes
that promote differentiation, survival, proliferation andmelano-
genesis. Themajority of published data onMITF-mediated gene
regulation comes from studies on melanocytes and melanoma
(21–25); however, similar classes of gene targets have been
identified in RPE (26–29). Highlighting its role in promoting
RPE differentiation, ectopic Mitf expression in quail neural
retina prompted conversion to RPE, whereas siRNA-mediated
knockdown ofMitf in chick RPE triggered loss of pigmentation
and upregulation of neural retina markers (30,31). Similarly,
Mitf2/2 null mutations in mouse resulted in abnormal prolifer-
ation and lack of pigmentation in RPE, partial conversion of
dorsal RPE to neural retina, and microphthalmia (small eyes)
(4,32,33). However, despite being essential for maintenance
and maturation of RPE, Mitf does not appear to be required for
RPE specification in mouse, zebrafish or chick (34–36).
Given its diverse influences during retinal and pigmented cell
development, it is perhapsnot surprising that theMitf/MITFgene
locus is highly complex, generating multiple isoforms via alter-
nate promoter usage and splicing, many of which show tissue-
specific expression (37–45). Eight human promoters have
been identified that drive transcription of a distinct lead exon
that splices into common downstream exons coding for the
DNA binding and protein interaction domains (40–43). No
information is available on MITF isoform expression during
human retinogenesis. However, several isoforms were shown
to be differentially expressed in developing mouse retina over
time, with RT-PCR analysis demonstrating the presence of
four in particular: Mitf-A, -D, -J and -H (39). Mitf-A and -J
were expressed at low levels in both neural retina and RPE,
while Mitf-H and -D were expressed in neural retina and RPE
at early time points but subsequently became restricted to
RPE. From a gene regulatory standpoint, Vsx2 was shown in
mouse to directly interact with the Mitf-H and -D promoters,
which coincided with the downregulation of these isoforms
(39). Furthermore, mouse mutant analysis showed that Vsx2
and Mitf are essential for OV patterning and their interaction
leads to the stabilization of the boundary between the developing
RPE and neural retina domains (4,11,12).
Very little is known about the expression profile and role of
MITF during early human eye development, largely because
OV patterning occurs within the first 3 weeks post-fertilization
when donor tissue is difficult to obtain for study. Information
from human patients with MITF mutations is limited as well.
Heterozygous MITF mutations leading to hypopigmentation
and deafness syndromes (Waardenburg and Tietz syndromes)
(9) havebeendescribed, but havenodemonstrable ocular pheno-
type. HomozygousMITF2/2 mutations are not known to exist,
and attempts to extrapolate Mitf 2/2 animal model findings to
humans are potentially complicated by species-specific gene
expression (4,15,45).
Recently, the potential to study early human retinal cell fate
decisions in vitro has become possible through the use of pluri-
potent stem cell differentiation protocols that recapitulate the
molecular and cellular hallmarks of retinogenesis (46–50).
Here, we have taken advantage of this methodology to investi-
gate the spatial and temporal expression of human MITF and
MITF isoforms in human embryonic stem cells (hESCs) at the
earliest stages of retinal differentiation. In addition, we exam-
ined interactions between VSX2 and the MITF gene locus,
which revealed a conserved mechanism for regulating neural
retina and RPE fate determination in hESCs. We then manipu-
latedMITF protein levels both by shRNA-mediated knockdown
and through generation of a nullMITF2/2 hESC line to further
investigate its function during human retinal differentiation.We
confirmed the requirement of MITF for normal RPE develop-
ment and identified a novel role for MITF in OV proliferation
prior to the neural retina versus RPE cell fate decision.
RESULTS
hESCs undergoing retinal differentiation demonstrate
conserved patterns of MITF expression
Weemployed our stepwise, three-dimensional retinal differenti-
ation protocol to generate OV, RPE, and neural retina cells from
WA09 hESCs in a time frame consistent with human develop-
ment (Supplementary Material, Fig. S1) (46–48). This protocol
relies upon endogenous signaling and cell–cell interactions to
prompt retinal neurogenesis and self-assembly of rudimentary
retinal structures (48). We focused initially on the expression
of MITF in early presumptive OV cells as they differentiated
from the primitive anterior neuroectoderm/eye field (AN/EF)
(Fig. 1). By day 10 (d10) of differentiation, over 90% of cells
adopted a PAX6+/OTX2+ AN/EF fate (data not shown),
which precedes the formation of both the forebrain and retina
(46,51). After an additional 2–3 days in culture, MITF was
detected in clusters within this cell population (Fig. 1A and B).
By d14–15, a subset of the MITF+ cells co-expressed VSX2
(Fig. 1C).By d20,VSX2 andMITFexpression becamemutually
exclusive (Fig. 1D–D′′ show high magnification views of the
transition zone between VSX2- and MITF-positive cell popula-
tions), resulting in spherical mounds of VSX2+/MITF2 cells
surrounded by flat skirts of VSX22/MITF+ cells (Fig. 1E).
Highly enriched neural retinal progenitor cell (NRPC) cultures
were generated by lifting the VSX2+ central mounds and iso-
lating the resulting phase bright OV-like structures (Fig. 1F)
as previously described (47,48,50). This process left behind
the surrounding cell skirts, which formed progressively pigmen-
ted monolayers with characteristic RPE morphology by d40
(Fig. 1G–I). The RPE cells uniformly expressed MITF, as
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Figure 1. Expression of MITF during early retinal differentiation in hESCs. (A) Immunocytochemistry (ICC) for PAX6 (red) and MITF (green) in adherent hESC
cultures differentiated for 13 days. The open and closed arrowsmark representative PAX6+/MITF+ and PAX6+/MITF2 cells, respectively. ICC for each of these
markers is shown separately in A′ (MITF) and A′′ (PAX6). (B) ICC for OTX2 (red) and MITF (green) in d13 adherent cultures. The open and closed arrowsmark
representative OTX2+/MITF+ and OTX2+/MITF2 cells, respectively. ICC for each of these markers is shown separately in B′ (MITF) and B′′ (OTX2). (C–E)
ICC for VSX2 (red) and MITF (green) in (C) d15, (D) d18 and (E) d20 adherent cultures. The open and closed arrows in C mark representative VSX2+/MITF+
and VSX2+/MITF2 cells, respectively. ICC for each of these markers is shown separately in C′ and D′ (MITF) and C′′ and D′′ (VSX2). Note that VSX2 and
MITF expression becomes mutually exclusive over this time period. (F) Light microscopic image of hESC-OVs collected at d20 after being lifted from adherent
cultures by gentle trituration. (G–I) Light microscopic images at sequentially higher magnifications showing differentiating RPE at d40 within the adherent skirt
of cells left behind after lifting the centralOVcolony.The asteriskmarks the former position of theOVcolony.The boxes outline the areamagnified in the subsequent
panel. (J) ICC image of ZO-1 (red) andMITF (green) inRPEpassaged from skirts surrounding former hESC-OVcolonies. Scale bars forA–D, J ¼ 20 mm; scale bars
for E–I ¼ 50 mm. Nuclei are counterstained with 4′,6-diamidino-2-phenylindole (DAPI) (blue).
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well as the tight junction protein ZO-1 (Fig. 1J). Thus, MITF
serves as the earliest known specific marker for OV cells in
hESCs, in addition to being a subsequent indicator for develop-
ing RPE.
A subset ofMITF isoforms is expressed in differentiating
hESCs and targeted for repression by VSX2
To further interrogate ourmodel system,wenext sought to deter-
mine which MITF isoforms were expressed in developing
human prenatal (hp) retina and hESC-derived OV and RPE
cells.At d67ofhuman retinal development, theRPE is apigmen-
ted, polarized monolayer and the neural retina consists of prolif-
erating NRPCs along with early-born retinal neurons. Day 67
prenatal eyes were dissected to isolate NR and RPE, following
which RT-PCR was performed using primers specific for the
unique 5′ ends of all eight humanMITF isoforms. PCR products
from the B isoform were robustly amplified from hpRPE only,
whereas the A,H andM isoforms were amplified from both pre-
natal RPE and prenatal neural retina samples (Fig. 2A, left
column). Products of two additional isoforms (D and E) were
faintly but consistently detected in prenatal RPE as well. Iso-
forms C and J were not detected in any retinal cells or tissues
tested. The same pattern of isoform expression was also found
in d115 prenatal RPE and prenatal neural retina (Fig. 2A, right
column); however, in dissected adult eyes, only MITF-A, -H
and -M were reliably detected in RPE, with MITF-A and -H
also seen in adult neural retina (Supplementary Material,
Fig. S2). RPE from differentiating hESC cultures showed a
similar MITF isoform expression pattern as human prenatal
RPE (Fig. 2B), but differed with regard to PCR product abun-
dance, possibly due to their relative immaturity compared with
d67 human prenatal RPE. Taken together, these results suggest
that developing human RPE expresses multipleMITF isoforms
and that the same general pattern of isoform expression occurs
in human embryonic stem cell-derived RPE.
In order to investigate MITF isoform expression in OV cells
prior to and during patterning intoRPEandneural retina,we per-
formed RT-PCR on differentiating hESC cultures at two stages:
d14 plated OV cells, a time point shortly after the initiation of
MITF isoform expression, and d20 lifted OVs, which harbor
newly establishedNRPCs.MITF-A, -H and -Mwere the predom-
inant isoforms detected in d14 OV cells and d20 OVs (Fig. 2B).
Table 1 summarizes the data for allMITF isoforms in human em-
bryonic stem cell-derived d14 OV cells and d20 OVs and RPE.
From this data, it appears that a number of MITF isoforms are
selectively upregulated in the transition from early, unpatterned
OV cell cultures to committed RPE.
Inmouse, theMitf-H and -D promoters are the primary direct
binding targets of Vsx2 in theOVduringRPE:neural retina pat-
terning (39). To determine which isoforms, if any, are targeted
byVSX2 inhESCs,weperformedchromatin immunoprecipita-
tion (ChIP) forVSX2ond30OVs, followedbyPCRanalysis for
pre-selected MITF isoform promoter regions containing con-
sensusVSX2binding sites. Day 30was chosen for these experi-
ments because VSX2 protein levels are consistently higher
compared with earlier time points (data not shown). Primers
flanking promoter regions free of consensus VSX2 binding
sites were used as negative controls (for detailed maps of the
consensus sites and primer locations, see Supplementary
Material, Fig. S3). VSX2 binding was detected in consensus
site-containing regions proximal to the MITF-D and -H
coding sequence start sites, but not within the pre-selected pro-
moter sites of the RPE-specific MITF-B isoform (Fig. 3A).
VSX2 also bound weakly to a consensus binding site 1780 nt
upstream of the MITF-A start site, although a consensus site
in a more proximal promoter region remained unbound.
Similarly, VSX2 has been shown to bind to the mouse Mitf-A
promoter with low affinity (39).
VSX2 is predominantly known for its role as a transcriptional
repressor in mouse (52–54). Therefore, we tested whether its
interactions withMITF promoter regions in hESCs also resulted
in transcriptional repression by ectopically expressing VSX2 at
d15 of differentiation, during OV patterning. Twenty-five days
later (d40), MITF isoform expression was decreased in lenti-
VSX2-infected cultures when compared with lenti-GFP-infected
cultures, as revealed by RT-qPCR (Fig. 3B). An 80% overall
Table 1. MITF isoform expression in human prenatal or hESC-derived retinal
tissue
Prenatal tissue hESC-derived
Isoform NR RPE d14 OV d20 OV (NRPC) RPE
A + + + + +
B 2 ++ 2 2 +
C 2 2 2 2 2
D 2 + 2 2 +
E 2 + 2 2 +
H + ++ + + ++
J 2 2 2 2 2
M + ++ + + +
Figure 2. MITF isoforms show differential expression during human retinal
development and hESC differentiation. RT-PCR for MITF isoforms from
(A) neural retina (NR) or RPE dissected from d67 or d115 prenatal eyes, or
(B) hESC-derived retinal cells (d14 adherentOVcells, d20 liftedOVs containing
NRPCs or d40 RPE).
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reduction in expression of MITF was observed, along with
respective 51% and 84% reductions in expression ofMITF-A and
-H, two isoforms robustly expressed at this time point (Fig. 3B;
pan-MITF: 1.07+0.27 versus 0.19+0.03, P, 0.03; MITF-A:
1.04+ 0.11 versus 0.51+ 0.12, P , 0.0005; MITF-H: 1.41+
0.41 versus 0.16+ 0.02, P, 0.008). To definitively ascribe
these reductions inMITF expression to VSX2-mediated repres-
sion, we transduced hESCs with a lentiviral construct that
expressed full-length VSX2 fused to the VP16 transcriptional
activator domain, which perturbs normal VSX2 function (53).
Ectopic expression of VSX2-VP16 in hESCs beginning at d15
did not reduceMITF expression comparedwith control cultures,
confirming a repressive role for VSX2 in MITF isoform tran-
scription during retinal differentiation (Fig. 3B).
In addition to repressing transcription of specific MITF iso-
forms, ectopic expression of VSX2 significantly reduced RPE
gene expression in hESC-derived retinal cells compared with
lenti-GFP-infected control cultures (Fig. 3C). We performed
RT-qPCR on d40 adherent cultures consisting mainly of devel-
oping RPE with some retained forebrain progenitors and
NRPCs. We observed decreased expression of direct down-
stream gene targets of MITF (TYR, BEST) in differentiating
RPE, as well as of other critical RPE genes (RPE65, MERTK).
However, expression of the forebrain marker DLX1 was un-
affected by ectopic VSX2 expression, demonstrating a specific
role of VSX2 in retinogenesis in hESCs as opposed to a general-
ized effect on neural development.
Lentiviral-mediated knock down ofMITF in hESCs
alters expression of both OV and RPE genes
To further investigate the role ofMITF during the early stages of
retinal differentiation, we created stable hESC lines expressing
MITF shRNA or non-targeting control shRNA (Fig. 4A). The
lentiviral constructs used to produce the knock down lines incor-
porated a bicistronic blasticidin resistance-IRES-eGFP cassette
Figure 3. VSX2 directly binds isoform-specific MITF promoter regions and
represses MITF expression. (A) PCR analyses following ChIP with either
VSX2primary antibody (V) or isotype control antibody (C). PCRwas performed
using primers flanking selected 500 bp promoter regions from four MITF iso-
forms. The presence or absence of a predicted VSX2 binding site within each
selected promoter region is indicated to the right of each image (note that not
all predicted sites were bound by VSX2). The location of the pre-selected pro-
moter regions respective to the translational start site of each MITF isoform is
shown in Supplementary Material, Figure S3. IN: input DNA. (B) RT-qPCR
forVSX2,panMITF,MITF-AandMITF-H fromd40adherent cultures transduced
at d15 with lenti-pgkVSX2 (hatched bars), lenti-pgkVSX2-VP16 (solid bars) or
control lenti-pgkGFP (open bars). (C) RT-qPCR for RPE markers (TYR,
BEST1,RPE65,MERTK) anda forebrainmarker (DLX1) ind40adherent cultures
transduced at d15 with lenti-pgkVSX2 (hatched bars) or control lenti-pgkGFP
(open bars). ∗P ≤ 0.04, ∗∗P ≤ 0.01, ∗∗∗P ≤ 0.0005.
Figure 4. Lenti-shRNA-mediated MITF knock down selectively decreases
expression of early OV and RPE genes. (A) Schematic depicting the method
used to generate and analyze clonal shRNA-expressing hESC lines following
lentiviral infection. Live cell fluorescence images of a representative GFP+
hESC colony before (A′) and after (A′′) selection and expansion. (B and C)
RT-qPCR analyses showing (B) early OV and forebrain gene expression levels
at d16 and (C) RPE gene expression levels at d40 in adherent MITF shRNA-
expressing hESC cultures (hatched bars) relative to non-targeted shRNA
control hESC cultures (open bars). Note that only RPE genes that are known
direct targets of MITF (TYR and BEST1) were reduced. Scale bars ¼ 50 mm.
∗P, 0.04, ∗∗P, 0.004, ∗∗∗P ≤ 0.0006.
6336 Human Molecular Genetics, 2014, Vol. 23, No. 23
and a shRNA expression cassette containing either a MITF-
targeting or non-targeting control sequence (Supplementary
Material, Fig. S4). Control and MITF shRNA hESC lines were
expanded and differentiated to d16 to assess the effect of
reduced MITF levels on early OV differentiation. Gene expres-
sion from three biological replicates of five independent MITF
shRNAlines and four independent control shRNAlineswas ana-
lyzed by RT-qPCR for markers of early OV differentiation
(Fig. 4B). Total MITF levels were reduced by 80% in MITF
shRNA versus control shRNA lines (0.24+ 0.02 versus
1.02+ 0.06, P, 0.0001). Concurrently, reductions in gene
expression of other early OV transcription factors were also
observed, ranging from 67% (PAX6: 0.33+ 0.08 versus
1.05+ 0.12, P, 0.0001) to 88% (LHX2: 0.12+ 0.03 versus
1.02+ 0.06, P , 0.0001). In contrast, the forebrain marker
DLX1 was expressed at similar levels in MITF shRNA and
control shRNA lines (1.09+ 0.14 versus 1.02+ 0.2), consis-
tent with a targeted effect of MITF knock down on early OV
differentiation.
To evaluate the effect ofMITF knock down onRPE specifica-
tion and maturation, we differentiated the MITF shRNA and
control shRNA hESC lines to d40 as adherent cultures and
assessed RPE gene expression levels by RT-qPCR. Reduction
of MITF expression to 48% of control levels resulted in corre-
sponding reductions in the expression of its direct transcriptional
targets TYR (0.33+ 0.02 versus 1.00+ 0.06, P , 0.009) and
BEST1 (0.33+ 0.03 versus 1.00+ 0.03, P , 0.004) (Fig. 4C).
However, expression levels ofRPEgenes not directly regulated
by MITF, such as RPE65 or MERTK, were not significantly
reduced in MITF shRNA versus control shRNA lines. Thus, a
partial reduction inMITF levels did not disrupt RPE specifica-
tion in hESCs, but did affect a subset of genes expressed in
developing RPE. Interestingly, despite the aforementioned
changes in OV and RPE gene expression, no difference in OV
or RPE phenotype was observed in the MITF knock down
hESC lines (Supplementary Material, Fig. S5). This finding
suggests either that the reduction in MITF expression achieved
in these experiments was insufficient to disrupt retinogenesis,
or that MITF is not required for normal retinal differentiation
in hESCs.
Elimination of MITF in hESCs reduces OV gene expression
and affects RPE development
To determine whether the complete absence of MITF activity
has a more profound effect on OV and RPE development in
hESCs than partial reduction, we employed bacterial artificial
chromosome (BAC)-mediated homologous recombination to
disrupt both MITF alleles in WA09 hESCs (Supplementary
Material, Fig. S6). To confirm that early eye field and OV cells
were produced in the absence ofMITF, theMITF2/2 knock-out
linewas differentiated for 13days and subjected to immunocyto-
chemistry (ICC) for the eye field transcription factors PAX6
and OTX2, which were expressed at this time point (Fig. 5A
and B). Later on, the presence of NRPCs was confirmed by
VSX2 immunoreactivity in d18 differentiated MITF2/2 cul-
tures (Fig. 5C). However, MITF expression was not detected
by ICC (Fig. 5B and C) or RT-PCR (Fig. 5D and F) at any
stage. Further analysis at d16 by RT-qPCR revealed reductions
in OV gene expression levels in MITF2/2 versus control
isogenic MITF+/+ cultures ranging between 75% (SIX3:
0.25+ 0.01 versus 1.01+ 0.12, P , 0.003) and 90% (LHX2:
0.10+ 0.02 versus 1.02+ 0.13, P, 0.003). Consistent with
the MITF knock down experiments, expression levels of the
forebrain marker DLX1 were not significantly changed in
MITF2/2 cultures, again confirming a selective effect of
MITF loss on retinal differentiation in hESCs (Fig. 5E).
At d40,MITF isoforms remained undetectable by RT-PCR in
MITF2/2 cultures (Fig. 5F), and expression levels of all MITF
target gene transcripts tested were significantly reduced relative
to isogenicMITF+/+ controls (Fig. 5G). Unlike in the shRNA-
mediated knock down experiments, markers of RPE fate that
are not directly regulated by MITF, such as RPE65 and
MERTK, were also significantly reduced in d40 differentiated
MITF2/2 hESCs.
With regard to phenotypic effects, the absence of MITF did
not wholly disrupt RPE specification, since cell skirts with
RPE-like morphology could be isolated and passaged from
MITF2/2 cultures. These RPE-like cells lacked MITF, failed
to pigment andmaintained adisorganized, immature appearance
even after 6 months in culture (Fig. 6A–D). However,
MITF2/2RPE demonstrated characteristic localization of the
tight junction marker ZO-1 and the nuclear transcription factor
PAX6, confirming their RPE identity (Fig. 6E–H). In addition,
we routinely passaged and expanded MITF2/2 RPE more than
three times, which cannot typically be achieved with wild-type
human pluripotent stem cell-derived RPE using our culture
system (55) (Supplementary Material, Fig. S7). Thus,
MITF2/2 RPE appears to remain in a more primitive state
when compared with isogenic controlMITF+/+ RPE.
The absence of MITF decreases proliferation in early
hESC-OV cells
In mouse, Mitf is initially expressed throughout the OV and
subsequently restricted to the RPE domain (4,5). Examination
of the MITF shRNA and MITF2/2 hESC lines revealed a
decrease in expression of markers of early, unpatterned OV
cells, prior to their commitment to either a neural retina or RPE
fate, consistent with a role for MITF in OV cell survival and/or
proliferation (Figs 4 and 5). Since MITF is known to regulate
apoptosis and proliferation in pigmented cell lineages (24), we
hypothesized that it performed similar functions in hESC-OV
cells. At d16, FACS analysis for Caspase-3, a marker of apopto-
sis, did not show a significant difference between MITF+/+ iso-
genic control and MITF2/2 hESC lines (data not shown). To
assess proliferative status in hESC-derivedOVcells, we identified
fields of adherent cells enriched for OV cells fromMITF+/+ cul-
tures at d18 by looking for VSX2+/MITF+ co-expressing
patches (SupplementaryMaterial, Fig. S8A).We then quantified
the percentage of cells in the region expressing the proliferation
marker Ki67. InMITF+/+ cultures, 23.2+ 2.2% of cells in the
developing OV regions were Ki67+ (Fig. 7A), most of which
(67+ 6%) co-expressed MITF. In differentiating MITF2/2
hESCs, fields enriched for OV cells at d18were identified by ex-
pression of VSX2 alone (Supplementary Material, Fig. S8B).
The percentage of Ki67+ nuclei in MITF2/2 OV regions was
significantly less than that found in MITF+/+ OV regions
(MITF2/2: 15.4+ 1.2% versus MITF+/+: 23.2+ 2.2%, P ¼
0.011) (Fig. 7A).
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Consistent with the decreased proliferation observed at early
time points during MITF2/2 hESC differentiation, lifted
hESC-OVs isolated from theMITF2/2 line at d20 were signifi-
cantly smaller than their MITF+/+ counterparts (Fig. 7B). We
measured the area of OVs differentiated in parallel from
MITF2/2 and MITF+/+ hESCs (n ¼ 3; total ¼ 140 MITF2/2
and 87 MITF+/+ hESC-OVs) and found that the average size
of MITF2/2 OVs was reduced 45% compared with the
average size of isogenic control OVs (MITF2/2: 5674+
287 mm2 versus MITF+/+: 8736+ 615 mm2; P , 0.0001).
However, starting at d30, growth of isolated MITF2/2
hESC-OVs paralleled that of MITF+/+ hESC-OVs (Fig. 7C
and Supplementary Material, Fig. S9A). Furthermore,
MITF2/2 hESC-OVs produced photoreceptor precursors that
co-expressed CRX and RECOVERIN by d65 in a similar
manner asMITF+/+ control hESC-OVs (SupplementaryMater-
ial, Fig. S9B). These data suggest that the earliest role ofMITF is
to support proliferation of unpatterned hESC-OV cells prior to
the adoption of a NRPC or RPE fate, after which time MITF
plays a role solely in RPE development.
DISCUSSION
Multiple studies have shown that human pluripotent stem cells
are capable of producing RPE and neural retina cell types in a
sequence and time frame akin to normal human retinogenesis
(46–50). We confirmed that MITF is expressed in discrete
patches of hESC-derived anterior neuroectoderm/eye field cells
prior to the appearance of VSX2, consistent with an early, unpat-
terned OV stage of retinal development. Subsequently, induction
of VSX2 in a subset of MITF+ hESC-OV cells heralded their
commitment to a NRPC fate. Our differentiation system, which
preserves cell–cell contacts and requires only a minimal, defined
mediumformulationwith fewexogenous signaling components,
promoted the co-development of RPE and NRPC domains in
tight spatial association with one another. These observations
reflect the potential for pluripotent stem cells to offer unprece-
dented insight into intrinsic molecular mechanisms underlying
the production of early human retinal cell types.
We performed a detailed investigation of MITF isoform
expression patterns in developing human tissue as well as in
Figure 5. Expression levels of early OV and RPE genes are reduced inMITF2/2 mutant hESCs relative toMITF+/+ isogenic control hESCs. (A and B) Immuno-
cytochemistry for (A) PAX6 (green) and OTX2 (red) and (B) MITF (green) and OTX2 (red) in d13 adherent MITF2/2 hESCs. (C) ICC for MITF (green) and
VSX2 (red) in d18 adherent MITF2/2 hESCs. Nuclei were counterstained with DAPI (blue). (D) RT-PCR for selected MITF isoforms from d16 MITF+/+ and
MITF2/2 hESC cultures. (E) RT-qPCR analysis showing expression levels of early OV and forebrain genes in MITF2/2 hESCs (hatched bars) relative to
MITF+/+ hESCs (open bars) at d16 of differentiation. (F) RT-PCR for selectedMITF isoforms from d40MITF+/+ andMITF2/2 hESC cultures. (G) RT-qPCR ana-
lysis showing expression levels of RPE genes inMITF2/2 hESCs (hatched bars) relative toMITF+/+ hESCs (open bars) at d40 of differentiation. Note that all RPE
genes tested were reduced in theMITF2/2 cultures. ∗P ≤ 0.02, ∗∗P, 0.003, ∗∗∗P ≤ 0.0006. Scale bars ¼ 20 mm.
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our hESC model of retinogenesis. Mitf is a complex genetic
locus with multiple promoters, many of which are expressed
in a tissue-specific or developmentally regulated fashion
(39,40,42,44,45,56). We detected six isoforms in developing
human RPE and in hESC-derived RPE, whereas only three
MITF isoforms were expressed in hESC-derived OV cells. Of
interest, the human MITF isoform expression pattern we
observed did not overlap completelywith publishedmouse data,
suggesting species-specific differences. For example, MITF-B,
an isoform readily amplified from maturing human RPE, was
not present in mouse RPE (39). It is unclear why only certain
MITF isoforms are expressed during retinal development and
whether some or all isoforms possess unique roles. However,
studies have demonstrated that the absence of either Mitf-D or
Mitf-M does not disrupt murine eye development, suggesting
at least partial redundancy in Mitf isoform function (29,57).
Our humanpluripotent stemcellmodel of retinogenesis is amen-
able tomolecular genetic manipulation, and thus should provide
a useful tool to investigate the roles of individualMITF isoforms.
Another notable feature of human pluripotent stem cells is
their ability to model molecular mechanisms of OV genesis
and retinal cell differentiation. In the present study, we showed
that VSX2 binds directly to promoter regions of several MITF
isoforms in hESC-OVs at a time when neural retina fate is
being established. In addition, ectopic expression of VSX2
repressed transcription of MITF and decreased expression of
RPE markers. Conversely, in a recent report we demonstrated
that differentiating hiPSC-OVs derived from a patient homozy-
gous for a VSX2 functional null mutation exhibited elevated
MITF levels and a neural retina-to-RPE fate conversion when
compared with sibling control hiPSC-OVs (50). Together,
these findings point toward reciprocal roles for MITF and
VSX2 in the establishment of the RPE and neural retina
domains in human pluripotent stem cells.
We also directly examined the impact of loss of MITF func-
tion on human RPE and OV development by creating MITF
shRNA-expressing andMITF2/2 hESC lines to either partially
knock down or fully knock out its expression. No phenotypic
effect on RPE specification and development was seen in
MITF knock down cultures, consistent with observations in
Mitf+/2 mice and humans with heterozygous MITF mutations
(reviewed in 9). Elimination of MITF expression also did not
prevent RPE specification; however, MITF2/2 RPE remained
unpigmented and developed abnormally compared with isogenic
control cultures, similar toMitf 2/2 mice (4,5,9,32–34).
The production of MITF shRNA and MITF2/2 hESC lines
also allowed us to definitively test whether MITF plays a role
in early OV development, prior to RPE specification. In contrast
Figure 6. RPE is produced inMITF2/2 hESCs but develops abnormally. (A) Western analysis for MITF and ACTIN protein in d60 second passageMITF+/+ and
MITF2/2 hESC-RPE. (B) Photograph of cell pellets frommatched, secondpassaged60MITF+/+ andMITF2/2 hESC-RPEgrown in parallel. (C andD) Lightmicro-
scopic imagesof d60secondpassageRPEfromMITF+/+ (C)orMITF2/2 (D)hESCcultures. (E–H) ICCimages fromd60secondpassageRPEfromMITF+/+ (Eand
G) orMITF2/2 (F andH) hESCcultures, showingMITF (green) andZO-1 (red) (E and F) or PAX6 (green) andZO-1 (red) (G andH) expression. Scale bars for C and
D ¼ 50 mm. Scale bars for E–H ¼ 20 mm.
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to RPE development, little is known about the function ofMITF
in unpatterned OV cells. In mouse, Mitf is initially expressed
throughout the OV and subsequently restricted to the future
RPE, while in chick it is expressed and maintained only in the
RPE region of the OV (4,5,15,16,26). Thus, there may be
species-specific differences in MITF function within the OV.
We observed decreases in expression of key transcription
factors during the early stages of OV development and pattern-
ing in the MITF knock down and knock-out hESC lines. The
reduction in transcription did not lead to a significant phenotype
in the knock down lines, most likely because therewas sufficient
MITF protein present. However, in the complete absence of
MITF protein,MITF2/2 hESC-OVs were significantly smaller
than isogenic control hESC-OVs upon initial isolation. This
finding, combined with the reduced proliferation seen in OV
cell-enriched regions of MITF2/2 hESCs, provides evidence
that MITF functions to promote proliferation in early human
OV cells.
VSX2 is upregulated in both MITF2/2 and wild-type
MITF+/+ hESCs during differentiation, which results in the
rapid elimination of MITF expression in NRPC-containing
OVs isolated from the latter group (46–48,50). It was therefore
not surprising that, in the absence of MITF expression, the
growth of bothMITF2/2 andMITF+/+ hESC-OVs closely par-
alleled one another. In contrast, we recently showed that long-
term growth, but not initial size, of VSX2 functional null
mutant hiPSC-OVs was reduced compared with wild-type
hiPSC-OV controls (50). Thus, MITF appears to control prolif-
eration in early, unpatterned hESC-OV cells, whereas VSX2
carries out this task in NRPCs following neural retina and RPE
domain specification.
Taking this information into account, we propose that during
the earliest stages of hESC-OV development, MITF primarily
influences cell proliferation before being downregulated in the
future neural retina domain by VSX2. Thereafter, it assumes
its more well-known role in RPE development. A similar dual
role for human MITF has also been described in neural crest-
derived melanocytes and melanoma cells (22–24). While it is
not clear what controls this switch in MITF function, several
studies have demonstrated that MITF activity can be influenced
by protein–protein interactions (7,29,58,59) as well as byMITF
protein levels (60–62). It is also possible that differential
isoform expression and/or alternative splicing events trigger
conversion between activities (38). Lastly, epigenetic factors
may impact MITF activity by restricting target gene sequence
access (25,63,64).
In summary, we have described an in vitro, pluripotent stem
cell-based model system of retinal development that can be
used to study multifaceted roles of transcription factors, begin-
ning at stages that cannot otherwise be investigated in humans.
While the degree to which hESCs can recapitulate complex
gene expression profiles andmolecular events is striking, poten-
tial limitations of the system need to be kept closely in mind.
For example, it does not take into account signaling cues and
mechanical forces from embryonic tissues that surround the
OV in vivo. To what extent these influences can be built in to
the model remains to be seen. However, the reliance of the
current system on default mechanisms of hESC differentiation
offers a starting point to investigate human development and
improve production and safety of cell derivatives for future clin-
ical applications.
MATERIALS ANDMETHODS
hESC culture and retinal differentiation
All tissue culture reagents were purchased from Life Technolo-
gies (Carlsbad, CA) unless otherwise noted.Methods for human
pluripotent stem cell culture and targeted retinal differentiation
have been described (46–48). Briefly, WA09 hESCs were
passaged and maintained on an irradiated mouse embryonic
fibroblast feeder layer (WiCell, Madison, WI) in hESC media
Figure 7. Elimination of MITF protein expression decreases early OV cell pro-
liferation and initialOV size, but does not affect subsequentOVgrowth. (A) Per-
centage of OV cells from d18 MITF+/+ (open bar) or MITF2/2 (hatched bar)
hESC cultures expressing the proliferation marker Ki67. (B) Graph showing
the mean area+S.E.M. of isolated d20 OVs from three independently differen-
tiated, paired cultures ofMITF+/+ (open bar) orMITF2/2 (hatched bar) hESCs.
(C) Pooled data plotted as percentage increase in OV size over time, relative to
d30 OVs from MITF+/+ (open bars) or MITF2/2 (hatched bars) hESC lines
(n ¼ 15 for each group). ∗P , 0.02, ∗∗∗P , 0.0001.
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[Dulbecco’s modified Eagle’s medium (DMEM):F12 (1:1),
20% Knockout Serum, 1% minimal essential medium (MEM)
non-essential amino acids, 1%L-glutamine,b-mercaptoethanol,
20 ng/ml FGF-2]. Retinal differentiation was initiated by lifting
embryoid bodies (EBs)with 2 mg/ml dispase and culturing them
for 3 days as free-floating, three-dimensional structures in hESC
media without FGF-2. On d4, suspended EB cultures were
switched to neural induction medium (NIM; DMEM:F12; 1%
N2 supplement, 1% MEM non-essential amino acids, 1%
L-glutamine, 2 mg/ml heparin) (51). On d7, EBs were plated on
laminin-coated plastic and allowed to form neural rosettes. At
d16, the loosely adherent neural clusters were gently lifted by
trituration and cultured as floating neurospheres in retinal differ-
entiation medium (RDM; DMEM:F12 (3:1), 2% B27 without
retinoic acid, 1% antimycotic/antibiotic) (46). At d18–20, OV
spheres were identified by their phase bright appearance and
manually separated from non-retinal neurospheres (47,48,50).
For RPE culture, the OV-depleted skirts of adherent cells were
also switched to RDM at d16 and maintained until d40 for mo-
lecular analysis or dissection and passaging, which was per-
formed as previously described (55).
Immunocytochemistry
To facilitate ICCanalysis, d7EBswere plated on laminin-coated
poly-L-lysine-treated glass coverslips and cultured for specified
lengths of time before being fixed with 4% paraformaldehyde.
For ICC on d65 OVs, spheres were fixed and cryosectioned as
previously described (48). For ICC on passaged RPE, cells
were cultured on coverslips for 2 months prior to fixation with
4% paraformaldehyde. Fixed samples were blocked with 10%
normal donkey serum and permeabilized with 0.5% Triton
X-100 (Sigma-Aldrich, St Louis,MO) prior to overnight incuba-
tion at 48Cwith primary antibodies diluted in 5% donkey serum
and 0.25%Triton X-100. A list of primary antibodies is found in
Supplementary Material, Table S1. Immunolabeled cells were
visualized with AF488-, AF546- or AF647-conjugated secondary
antibodies and nuclei were counterstained with 4′,6-diamidino-
2-phenylindole [(DAPI) Life Technologies]. Cells were imaged
on either a Nikon 80i or a Nikon C1 laser scanning confocal
microscope (Nikon Corp., Tokyo, Japan).
Human prenatal eye dissection and processing
Postmortem human prenatal eyes were obtained from the Birth
Defects Research Laboratory (Seattle, WA) according to proto-
cols approved by theNIH and the Institutional ReviewBoards at
the University of Wisconsin–Madison and the University of
Washington. Eyes were dissected and processed as previously
described (65). Briefly, neuroretina from gestational Day 67 or
115 eyes was separated from underlying RPE and transferred
to RNeasyw buffer RLT (Qiagen, Valencia, CA) containing
b-mercaptoethanol for RNA isolation. The remaining RPE
was then transferred to buffer RLT for RNA isolation.
Gene expression analysis
Total RNAwas extracted from cell and tissue samples using the
RNeasy mini kit (Qiagen, Valencia, CA) according to the man-
ufacturer’s instructions,which included aDNase incubation step
to remove contaminating genomic DNA. One microgram of
RNA was reverse transcribed using the iScript cDNA synthesis
kit (BioRad, Hercules, CA), and PCR was carried out with 2x
PCR Master Mix (Promega, Madison, WI) for 30 cycles (558C
annealing temperature), followed by analysis on 1–2%
agarose gels containing ethidium bromide. Quantitative PCR
analysis (qPCR) (35 cycles) was performed with SsoAdvanced
SYBRw Green supermix on a C1000 thermocycler equipped
for real-time PCR detection (BioRad). All qPCR experiments
utilized at least three biological replicates. Results were ana-
lyzedwithMicrosoft Excel andGraphPadPrism 5 and presented
as average 22DDCq+SEM for all reactions. Primer sequences
are listed in Supplementary Material, Tables S2 and S3 for
RT-PCR and RT-qPCR, respectively.
Protein expression analysis
RPE or HEK293 cells were collected and snap frozen, after
which the cell pellets were lysed in RIPA buffer (Pierce, Rock-
ford, IL) with 40 ml/ml protease inhibitor cocktail (P8340;
Sigma-Aldrich, St Louis, MO), cleared by centrifugation, and
quantified by Lowry assay. Protein samples (30–50 mg) were
loaded onto 10% Tris–HCl Ready gels (BioRad), separated by
SDS-PAGE, and electroblotted in 20% methanol Tris/glycine
transfer buffer onto PVDF-Licor membranes (Millipore, Biller-
ica, MA). PVDF membranes with transferred protein were then
placed in Odyssey blocking buffer (LiCor, Lincoln, NE) for 1 h
at RT followed by overnight incubation with primary antibody
[MITF: Exalpha (Shirley, MA) C5 mouse monoclonal, 1:250;
ACTIN: Millipore mouse monoclonal, 1:1000] in blocking
buffer + 0.1% Tween20 at 48C. Thereafter, membranes were
washed with PBS/0.1% Tween20 and incubated with 1:10 000
diluted donkey a-mouse IRdye 800CW secondary antibody
(LiCor) in blocking buffer + 0.1% Tween20/0.01% SDS for
1 h. Immunoblots were washed with PBS/0.1% Tween20
and protein bands were visualized with an Odyssey Infrared
Imager (Licor).
Chromatin immunoprecipitation
OVsweremanually isolated (47) at d18–20 anddifferentiated to
d30 in RDM. OVswere then crosslinked with 1% formaldehyde
at RT with shaking for 10 min, followed by neutralization with
125 mM glycine. Subsequently, crosslinked OVs were lysed in
RIPA buffer (Pierce, Rockford, IL) with 40 ml/ml protease
inhibitor cocktail (P8340; Sigma) and sonicated in a Q700 ultra-
sonic processer (Qsonica, Newtown, CT) equipped with a cup
horn. The size range of sheared DNA was monitored by
running samples on 1% agarose gels. Immunoprecipitation was
performed overnight at 48C with 2 mg of either goat anti-VSX2
primary antibody (1 mg each of the C17 and N18 antibodies,
Santa Cruz, Dallas, TX) or normal goat IgG (Millipore). Com-
plexes were collected with protein G-conjugated Dynabeads
(Life Technologies), washed, eluted in 10 mM Tris HCl/1 mM
ethylenediaminetetraacetic acid (pH 8)/1% SDS, and heated at
658C to reverse the crosslinks. Samples were then diluted with
sterile water and DNA was extracted with an equal volume of
phenol:CHCl3:isoamyl alcohol (1:1:24; Ambion/Life Tech-
nologies) followed by ethanol precipitation. PCR analyses (35
cycles) on input DNA, control immunoprecipitated (IP) DNA,
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and VSX2 IP DNA were performed using 2× PCRMaster Mix
(Promega) and promoter-specific primer sets, and the resulting
PCR products were visualized on a 2% agarose gel containing
ethidium bromide. Supplementary Material, Table S2 lists the
primer sequences used and Supplementary Material, Figure S3
shows the relative locations of the primer sets and consensus
VSX2 binding sites in selected MITF isoform promoter
regions. Potential VSX2 consensus binding sites were identified
either via homology to previously published mouse VSX2
binding sites (39) or by predictions made using the web-based
PROMO algorithm within 3 kb regions upstream of MITF
isoform transcription start sites (http://alggen.lsi.upc.es/cgi-
bin/promo_v3/promo/promoinit.cgi?dirDB=TF_8.3; 66,67).
Ectopic expression of VSX2 or VSX2-VP16 fusion protein
The pSIN-mpgk-VSX2 expression plasmid and the procedure
for lentivirus-mediated ectopic protein expression in differenti-
atinghumanpluripotent stemcells havebeendescribed (50).The
pSIN-mpgk-VSX2-VP16 plasmid was constructed by PCR
amplifying the equivalent coding sequence from the pMXIE-
ChxV plasmid (53) and cloning it into the pSIN-WP-mpgk len-
tiviral shuttle backbone (68).Lentiviruswasproduced according
to standard protocols (69).Viruswas 40× concentrated by ultra-
centrifugation and working titers were determined by infecting
HEK293T cells and performing VSX2 ICC or directly visual-
izing eGFP fluorescence at 48 h post-infection. Equivalent
working titers of the pSIN-mpgk-VSX2, pSIN-mpgk-VSX2-
VP16, and pSIN-mpgk-GFP lentiviruses were used to transduce
plated hESC-EBs at d15. Control infections yielded .70%
GFP+ cells.
Generation ofMITF shRNA hESC lines
A short interfering RNA sequence that targetsMITF effectively
was previously identified (56) (Supplementary Material,
Fig. S4). For a non-targeting, control sequence, we used NC-1
(Integrated DNATechnologies, Coralville, IA) (Supplementary
Material, Fig. S4). Oligonucleotides encoding stem loop struc-
tures with AgeI and EcoRI overhangs were cloned into a modi-
fied pLKO.1 vector with the puroR coding region replaced by a
GFP-ires-blasticidin resistance cassette (70). The specificity of
MITF transcript knockdown was validated by transfecting the
MITF-targeting shRNA plasmid or the non-targeting shRNA
plasmid into HEK293 cells along with a MITF ectopic expres-
sion plasmid and performing Western analysis for MITF
protein (Supplementary Material, Fig. S4B). Following valid-
ation of the MITF and control shRNA sequences, lentivirus
was made as described above. To generate stable lines, WA09
hESCs were passaged on Matrigelw in mTesR1 (WiCell) to
facilitate drug selection. Cells were dissociated with Versene
(Life Technologies), mixed with lentivirus (titered as described
above), and incubated for 30 min at 378C in 1 ml mTeSR1 +
10 mM Y-27632 (PeproTech, Rocky Hill, NJ) before re-plating
onMatrigelw. Infection efficiency was monitored by GFP fluor-
escence, and blasticidin selection (2 mg/ml) was started 48 h
after infection. Non-clonal stable populations were dissociated
to single cells, counted, diluted to 10 cells per 100 ml in
mTeSR1 + Y-27632, and dispensed into individual wells of a
96-well plate. After 2 weeks, GFP+ colonies from separate
wells were manually picked, plated onto MEF, and cultured as
undifferentiated hESCs as described above.
Generation ofMITF knock-out hESC lines
A BAC clone (RP11-378D21: GRCh37/hg19 assembly chr3:
69897000-70055107) containing the MITF locus was modified
by standard recombineering techniques using the Red/ET
system (Genebridges, Heidelberg, Germany). A cassette encod-
ing the human EF1a promoter driving a puromycin resistance
gene and flanked by loxP sites was inserted within the second
common exon (exon 3) of theMITF locus, disrupting transcrip-
tion from the upstream promoters (Supplementary Material,
Fig. S5). The construct was linearized by AscI restriction diges-
tion and transfected by electroporation intoWA09hESCs as pre-
viously described (71). Successfully targeted clones were
isolated by puromycin selection and identified by qPCRanalysis
of genomic DNA to assessMITF copy number. A clone identi-
fied in this manner was expanded and the selection cassette
was subsequently excised via transfection of mRNA encoding
Cre recombinase. Removal of the cassette was confirmed by
genomic PCR and loss of resistance to puromycin. To generate
aMITF2/2 line from the single targeted clone, the sameMITF
gene-targeting construct was again introduced by electropor-
ation and puromycin resistant clones were isolated. A knock-out
line was confirmed by PCR analysis of genomic DNA using
primers flanking the target site in the MITF gene. Absence of
MITF expression was confirmed by RT-PCR, ICC and Western
blotting (Figs. 5 and 6).
OV growth assay
Fifteen OVs each were selected from day 30 MITF+/+ and
MITF2/2 OVs, placed in individual wells of a 96-well plate,
and maintained in RDM until 65 days of differentiation. Bright
field photographs of each OV were taken every 3–5 days
using a Nikon Cool Pix camera attached to a Nikon TS100
invertedmicroscope andmeasured with Nikon Elements D soft-
ware to calculate OV area. OV size at each time point was nor-
malized to its size at d30 and average growth+SEM for all
OVs was plotted for each time point.
Live cell imaging, cell counts and statistics
All live cell imaging,with the exception of the growth curve ana-
lysis (see above), was done with a QImaging CE (Surrey, BC,
Canada) CCD camera attached to a Nikon TS100 inverted
microscope equipped with epiflourescence. Measurements of
d20 OV area and Ki67+ or MITF+ cell percentage were made
using the Nikon Elements module D 3.2 taxonomy feature on
photomicrographs or confocal images. Graphs were plotted
with Graph Pad Prism 5.0, which was also used for statistical
analysis. All data are presented as mean+SEM. Significance
was determined with a two-tailed unpaired Student’s t-test at
95% confidence.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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